Cytotoxic agents comprising maytansinoids and their...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 498/14 (2006.01) A61K 31/365 (2006.01) A61K 31/535 (2006.01) A61K 31/537 (2006.01) A61K 39/44 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07K 7/04 (2006.01)

Patent

CA 2026147

8~A cytotoxic agent comprising one or more maytansinoids linked to a cell binding agent. A therapeutic agent for killing selected cell populations comprising: (a) a cytotoxic amount of one or more maytansinoids linked to a cell binding agent, and (b) a pharmaceutically acceptable carrier, diluent or excipient. A method for killing selected cell populations comprising contacting a cell population or tissue suspected of containing cells from said selected cell population with a cytotoxic amount of a cytotoxic agent comprising one or more maytansinoids linked to a cell binding agent. An N-methyl-alanine-containing ester of maytansinol or an analogue of maytansinol, said N-methyl- alanine-containing ester comprising a linking group capable of linking an N-methyl-alanine-containing maytansinoid ester to a chemical moiety. N-methyl-cysteine-containing ester of maytansinol or an analogue of maytansinol.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cytotoxic agents comprising maytansinoids and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytotoxic agents comprising maytansinoids and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic agents comprising maytansinoids and their... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1880445

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.